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ABSTRACT: Cultured skin substitutes have provided a
new approach for the closure of wounds, but these avascular
grafts are subject to microbial destruction that may lead to
tissue infection. To minimize wound infection, HN-300 (a
new inorganic antimicrobial particle) was incorporated into
the collagen–chitosan wound dressing. Antimicrobial, cyto-
toxicity, release rate, swelling, and mechanical properties of
this material were assessed. The antimicrobial property was
enhanced with the increasing dosage of HN-300. When the
concentration of HN-300 was more than 5%, the films
showed sustained and stable antimicrobial property within
144 h. When the concentration of HN-300 was less than
7.5%, the wound dressings were noncytotoxic and compatible
for L929 fibroblasts. So 5% HN-300 in antimicrobial films
was suitable and the concentration also could improve the
mechanical properties of the collagen–chitosan wound
dressings. After treatment with 5% glycerol, the film’s stabil-
ity was enhanced and silver ions were protected at the same
time. Hence, collagen/chitosan/HN-300 films are of great
potential in application as wound dressing in future,
because of their good biosafety and physical proper-
ties.  2007 Wiley Periodicals, Inc. J Appl Polym Sci 105: 1679–
1686, 2007
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INTRODUCTION
Cultured skin substitutes have provided a new
approach for wound healing. Collagen was one of the
most promising materials for its excellent biocompati-
bility and biodegradability.1 As the main composition
of extracellular matrix, collagen improved the adhe-
sion, proliferation, and differentiation of cells in tissue
culture.2 Chitosan was used in various biomedical
fields such as drug delivery carrier, surgical thread,
and wound healing materials,3 and it also could
improve the function of collagen films, such as me-
chanical property, swelling property, and biodegrad-
ing rate.4 Collagen and chitosan could form a polyan-
ion–polycation complex when the concentration of
chitosan was more than 10 wt %.5 So the composites
of collagen and chitosan were ideal materials for skin
substitutes. To minimize wound infection risk of these
avascular grafts, antimicrobial drugs such as broad
spectrum antiseptic agents (iodine and silver) and
antibiotics should be used. Silver was widely used as
one of broad spectrum antiseptic agents, owing to its
ability to sterilize varieties of disease—caused by
microbes such as aerobe, anaerobe, yeast, fungi, and
virus.6 In addition to the antimicrobial properties, sil-
ver also showed anti-inflammatory properties.7 Silver
exerted its antimicrobial effects by interfering with the
respiratory chain on the cytochromes and components
of the microbial electron transport system. Silver also
could bind DNA and inhibit DNA replication.8 Tradi-
tional silver antimicrobials such as silver nitrate and
silver sulfadiazine were limited in their stimulation
and quick inactivation. In this research, a new type of
silver antiseptic agent HN-300 was incorporated into
the collagen–chitosan films.
As wound dressing, collagen–chitosan films com-
plexed with antimicrobial agent, which should be
crosslinked to keep its structural stability in moist
wound environment. Glutaraldehyde and 1-ethyl-3-
(3-dimethyl aminopropyl) carbodiimide (EDC) were
ordinary crosslink agents. Glutaraldehyde could
crosslink collagen and chitosan efficiently at the same
time, but it was generally thought to result in cytotox-
icity.9,10 Using both EDC and glutaraldehyde needed
extensive washing to get rid of residua, but in the pro-
cess of washing, silver ions would get lost greatly
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from collagen/chitosan/HN-300 films. The antimicro-
bial films did not need to be deeply crosslinked, since
the antimicrobial films would be used on the surface
of body and it was convenient to be changed. Glycerol
just satisfied the need. Recent studies indicated that
the collagen structure was stabilized by direct intra-
molecular interactions with polyhydric alcohols,11 and
that glycerol could stabilize collagen solvation shell.12
Therefore, glycerol was used as the post-treatment
agent of the antimicrobial films. The antiseptic effi-
ciency, cytotoxic property, release amount, and the
swelling capacity of the collagen/chitosan/HN-300
films were investigated in this article.
EXPERIMENTAL
Materials
Chitosan (Mw: 2  105, 90.6% deacetylated) was pur-
chased from the Third Institute of Oceanography of
the State Oceanic Administration of China (Xiamen
City, Fujian Province, China). Collagen type I was sep-
arated from fresh bovine tendon according to our
reported method.13 HN-300 was donated by the
Jiangsu Hehai Group of the Chinese Academy of Sci-
ences (Taixing City, Jiangsu Province, China). HN-300
containing 3% (w/w) silver was produced by the
exchange of silver ions and NaZr2(PO4)3 ion exchange
carriers. Agþ and Ag2þ were the main antimicrobial
components in HN-300. The diameter of HN-300 par-
ticle was about 300 nm.
Preparation of collagen/chitosan/HN-300 films
Collagen (CO) or chitosan (CH) was dissolved in
0.05M acetic acid to prepare a 0.5% (w/w) solution,
respectively. HN-300 was dispersed in the chitosan so-
lution by stirring and ultrasonication. The HN-300
solution was then dropped slowly into the collagen so-
lution with the volume ratio of 1:9 (VCH:VCO ¼ 1:9) and
homogenized by stirring. The collagen–chitosan solu-
tion was dropped on a polytetrafluorethylene plank
and dried for 24 h at 378C. The same way was used to
prepare comparative samples with the amount of silver
equal to that of films, with 5% or 10% HN-300.
To improve the stability, these antimicrobial films
were immersed in 5% glycerol in water for 1 h and
washed with triply distilled water (30 min  5 times),
and then dried for 24 h at 378C.
Swelling test
The collagen/chitosan/HN-300 films with or without
glycerol treatment were placed into distilled water at
room temperature, and the wet weight (w) of the film
was determined after incubation for 24 h. The swelling
ratio of the films was defined as the ratio of weight
increase (w  w0) to the initial weight (w0). Each value
was averaged from six parallel measurements.
Silver release assay
Collagen/chitosan/HN-300 films and comparative
samples with AgNO3 were immersed in phosphate
buffer saline (PBS) (1 cm2 film/mL PBS), respectively.
The whole apparatus was placed in a water bath
shaker at 378C and shaken at 200 rpm. PBS was
removed and replaced with fresh medium every 24 h,
and the concentration of silver in the extract was
examined through atomic absorption spectrometry.
Antibacterial test
Escherichia coli (E. coli) DH5a was proliferated in liquid
Luria-Bertani (LB) culture medium for 14 h at 378C,
and was shaken at 180 rpm. The optical density of the
bacterial suspension was measured with ultraviolet
spectroscopy (UV-2550) at 600 nm. Hundred micro-
liters of bacterial suspensions were evenly pipette-
loaded on the solid LB culture medium in a dish. Then
the LB medium was covered with round pieces of
tested films and a filter paper with the same diameter
as blank experiment, respectively. The dishes were
put in an incubator (378C, 5% CO2). Photos were taken
after incubation for 12, 36, 50, and 144 h, respectively.
Cell compatibility assay
Five kinds of collagen/chitosan/HN-300 films (the
weight percent of HN-300 was 0%, 2.5%, 5%, 7.5%, and
10%, respectively) were immersed in 75% ethanol ultra-
sonicated for 30 min, washed two times in PBS, and air-
dried in a super clean bench. The films (1 cm2/mL)
were then immersed in 1640 culture medium, with 10%
bovine serum and incubated for 24 h at 378C. About 1.96
mL extraction (or 1.96 mL medium as negative control)
was added to each well of 24-well polystyrene plates.
About 0.04 mL suspension of L929 fibroblasts (5  105
cells/mL) was seeded in each well. Plates were cultured
in an incubator (378C, 5% CO2) for 5 days. On the 1st,
3rd, and 5th day, the culture medium of one plate was
removed and 200 mL MTT (0.25 mg/mL) was added to
each well, and the plates were incubated for 4 h and
then 600 mL of DMSO was added. After incubation for
1 h, absorbance (A) was measured at 490 nm against
blank (DMSO). Cell toxicity of pure HN-300 was also
checked with the same method.
The cell viability (CV) was calculated according to
the following formula:
CV ¼ ASample  100=AControl
Sterilized film sample (12 mm in diameter) was put
in each well of a 24-well plate, and then 2 mL com-
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plete medium and 1  104 L929 cells were added. The
plate was cultured in an incubator (378C, 5% CO2) for
4 days. These specimens were fixed in 2.5% glutaral-
dehyde in 0.1M sodium cacodylate buffer (pH ¼ 7.2)
at 48C for 30 min and then dehydrated in a graded se-
ries of alcohols. In the end, these specimens were
observed using a scanning electron microscope (SEM,
LEO1530).
Mechanical property
The mechanical property was measured by a multi-
functional electron mechanical analyzer (WDS-5,
Shanghai Shenlian Testing Machineries Works) at a
crosshead speed of 20 mm/min. The studied samples
were cut to 110 6 1 mm in length and 10 6 0.5 mm in
width for the test.
RESULTS ANDDISCUSSION
Swelling test
The holding water ability of a film was an important
parameter to evaluate its property for wound dress-
ing. High swelling ratio might prevent the wound
from accumulation of unwanted body fluid by the
adsorption of exudates. It also assured moist wound
environment, which would be helpful for therapy.14
However, as the swelling ratio was higher than
5000%, the strength of swelled collagen/chitosan/
HN-300 films decreased sharply. The films had no
strength after 24-h swelling in water, and so a suitable
swelling ratio of antimicrobial films was necessary.
Figure 1 showed the swelling ratios of these films with
different amount of HN-300 in various conditions.
The swelling ratio of collagen–chitosan films
untreated by glycerol decreased with the increase of
HN-300 from 2.5% to 10% obviously. Therefore, when
the concentration of HN-300 was more than 2.5%, the
swelling ratios were lower than that of the pure colla-
gen–chitosan films. The films with over 5 wt % HN-
300 had good strength after 24-h swelling in water.
The result indicated that HN-300 could strengthen col-
lagen–chitosan films. To improve the film strength in
low concentration of HN-300 (too much HN-300 was
harmful to cell, see Cytotoxicity Assay section), the
collagen/chitosan/HN-300 films were treated with
5 wt % glycerol solution. The swelling ratio of treated
films decreased obviously compared with untreated
films, and decreased hardly with the increase in con-
centration of HN-300. The result suggested that glyc-
erol could decrease the swelling ratio of these films.
All films treated by glycerol had good strength after
24-h swelling in water, and then the concentration of
HN-300 in antimicrobial films was not restricted by
swelling ratio.
Release amount of silver
The in vitro release amount of silver from collagen/
chitosan/HN-300 films within 7 days was showed in
Figure 2. The release amount reached about 45% in
films with 2.5% HN-300 on the first day, which
showed a typical initial burst effect, while the release
amount only reached 12% in films with 10% HN-300.
These results indicated that the initial burst drug
release was retarded with the increasing amount of
HN-300. The release amount of silver in the films with
the concentration of HN-300 from 5 to 10% reached
Figure 1 The effect of the concentration of HN-300 on the
swelling ratios of collagen–chitosan films treated by 5% glyc-
erol and untreated, respectively. Values are mean 6 SD (n¼ 4).
Figure 2 The release profiles of silver from 2.5%, 5%, 7.5%,
10% HN-300-containing collagen–chitosan films. All films
were treated with 5% glycerol for 1 h. Values are mean 6 SD
(n ¼ 4).
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above 98% after 7 days. The release amount of silver
in the films with 2.5% HN-300 reached about 80%
after 7 days.
Comparative samples (collagen/chitosan/AgNO3
films) were used in this experiment. The release pro-
files of the comparative samples were shown in Fig-
ure 3. On the first day, the release amount of compara-
tive samples was just a little lower than that of the
experimental samples (collagen/chitosan/HN-300 films)
with equivalent silver. Over the next few days, the
release amount of silver from comparative samples
fell off rapidly, and the release stopped after the fifth
day. From the beginning to the fifth day, the release
amount of silver from the films with the concentration
of silver equivalent to 5 and 10% HN-300 were 44.6%
and 57.7%, respectively. The values were less than
that of the experimental samples (98%). What does
this show? Here a phenomenon should be mentioned.
In the process of preparing AgNO3/chitosan solution
through stirring and ultrasonication, the color of the
solution changed from transparent to gray as shown
in Figure 4. Four kinds of solution prepared with
0.05M acetic acid were shown in Figure 4. They were
(a) the solution with 0.025% AgNO3, (b) the solution
with 0.5% chitosan, (c) the solution with 0.5% chitosan
and 0.025% AgNO3, and (d) the solution with 0.5%
chitosan and 0.5% HN-300. The comparison of (a), (b),
and (c) showed that the change of solution color hap-
pened only in chitosan solution containing AgNO3.
Being combined with silver ions, oxygen in the air
may make silver ions oxidized and form silver oxides
on the condition of heating or exposure to light. In the
experiment, 0.025% AgNO3 solution (a) did not
change in color obviously. It meant the energy, includ-
ing the heat produced by ultrasonication or exposure
to light, was not enough to form silver oxides. Why
gray silver oxides could form in the solution c?
According to the research of Yoshizuka,15 chitosan
could be used to adsorb various metal ions in solution
including silver ions. In the experiment, the silver–chi-
tosan composed of a catalytic activity system, and it
accelerated the formation of silver oxides. Figure 3
showed that about half of silver in comparative samples
could not release effectively to exploit its antimicrobial
Figure 3 The release profiles of silver from HN-300 con-
taining collagen–chitosan films and AgNO3 containing colla-
gen–chitosan films. HN5: 5 wt % HN-300, HN10: 10 wt %
HN-300, AN5 and AN10: the amount of silver in collagen/
chitosan/AgNO3 films was equal to the amount in the colla-
gen/chitosan/HN-300 films with 5 and 10% HN-300,
respectively. All films were treated with 5% glycerol for 1 h.
Values are mean 6SD (n ¼ 4).
Figure 4 The image of the solutions prepared with 0.05M
acetic acid. (a) 0.025% (w/w) AgNO3, (b) 0.5% (w/w) chito-
san, (c,d) 0.5% (w/w) chitosan solution containing 0.025%
AgNO3 and 0.5% HN-300, respectively.
Figure 5 The image of the inhibition zones around HN-
300-free collagen–chitosan films after incubation for 12 h. a,
filter paper; f, collagen–chitosan films (collagen:chitosan
¼ 9 : 1 (wt)).
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ability. In the same condition, HN-300 as new inor-
ganic antimicrobial particle defended oxidization and
protected silver effectively in the process of preparing
experimental samples. It explained the reason for
using HN-300.
To test the release form of silver from collagen/chi-
tosan/HN-300 films, the extract of these experiment
samples was centrifuged at 20,000 rpm, and then the
concentration of silver in the supernatant layer was
also examined through atomic absorption spectrome-
try. No difference in concentration was found between
the extraction and its supernatant layer. The result
indicated the silver ions were released by ion
exchange, and not by HN-300 nanoparticles or local
material degradation.
Antimicrobial character
The aim of the present study was to develop an anti-
microbial collagen–chitosan wound dressing. Chitosan,
an alkaline mucopolysaccharide, exerts its antimicro-
bial effects by two mechanism16: (1) NH3
þ groups of
chitosan prevent nutrients from entering the cell to
interfere bacterial metabolism by adsorbing bacterial
cell membrane with negative charge and form a poly-
mer membrane, (2) NH3
þ groups of chitosan flocculate
cells by adsorbing the cellular electronegative sub-
stance, disturb the physiological activities of the bacte-
ria, and kill them via pervasion.17,18
In the present study, the antimicrobial property of
the films with 10% chitosan was examined. After put-
ting collagen/chitosan films into dishes for bacterial
culture (E. coli. DH5a), the dishes were incubated for
12 h at 378C, and no inhibition zone was observed
around these specimens (Fig. 5). This result seemed to
conflict with the antimicrobial property of chitosan
that was reported in acid solution.16–18 NH3
þ groups
of chitosan exist only in the acid environment; thus,
almost no NH3
þ groups appear in the neutral culture
environment of bacteria (pH 7.4) in the experiment.
That was why chitosan-containing films did not in-
hibit proliferation of bacteria around the sample as
shown in Figure 5. In addition, collagen may be help-
ful for bacteria adherence and shield the immunology
reaction of the host from bacteria.19 To increase its
antimicrobial property, it was thus necessary to de-
velop a new type of antimicrobial wound dressing by
adding antibacterial.
The antimicrobial capacity of metallic ion descends
in the following order: Ag > Hg> Cu > Cd > Cr > Ni >
Pb > Co > Zn > Fe.20 Silver was chosen in our
study to provide the collagen–chitosan wound dress-
ing with antimicrobial property. Traditional silver
antimicrobials, such as silver nitrate and silver sulfa-
diazine, were limited in clinic use for their quick inac-
tivation; moreover, silver sulfadiazine was commonly
applied twice per day and silver nitrate up to 12 times
per day, and such frequent dressing changes would
greatly afflict burn patients.8 HN-300 was an ideal
antimicrobial for its good stability. As shown in Figure
6, the inhibition zone around the films, whose diame-
ters reflected the antimicrobial efficiency, enlarged
with the increasing concentration of HN-300. It was
because silver ions were the main antimicrobial com-
ponents in HN-300. The number of silver ions was
mainly influenced by the dosage of HN-300. When
antimicrobial films contacted body fluid, ion exchange
Figure 6 The image of the inhibition zone of HN-300-con-
taining collagen–chitosan films with different ratios (wt)
after incubation for 12 h. a, filter paper; b, 10%, c, 7.5%, d, 5%;
e, 2.5%.
TABLE I
Antimicrobial Activity of Collagen/Chitosan/HN-300 Films Illuminated by the Inhibition Zone Diameters (mm)
Incubation time
Concentration of HN-300 (wt %)
Blank 2.5% 5% 7.5% 10%
12 h 9.0 6 0.1 10.3 6 0.2 14.2 6 0.5 14.4 6 0.1 14.8 6 0.2
36 h 9.1 6 0.1 10.1 6 0.2 10.8 6 0. 4 11.4 6 0.4 12.3 6 0.3
60 h 9.1 6 0.1 9.5 6 0.4 9.9 6 0.6 11.4 6 0.6 11.7 6 0.6
144 h 9.0 6 0.3 9.1 6 0.2 9.6 6 0.2 10.2 6 0.1 10.4 6 0.2
Values are mean 6 SD (n ¼ 4).
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happened between cations in body fluid and silver
ions in collagen/chitosan/HN-300 films. As shown in
Table I, the inhibition zone appeared after 12-h incu-
bation, and then decreased with time. These results
indicated that some bacteria resumed growth near the
outer edge of the inhibition zone. The inhibition zone
of the films with the concentration of HN-300 ranged
from 2.5% to 10% and were significantly different
from that of the controlled filter paper in 36 h, while
the inhibition zone of the films with 2.5% HN-300
were similar to that of the controlled filter paper after
36 h. Only the films with the concentration of HN-300
ranging from 5 to 10% showed sustained and stable
antimicrobial property within 144 h.
Cytotoxicity assay
Cytotoxicity of antimicrobial films’ extraction was a
very important parameter to evaluate biomaterials. In
the present study, the extraction of collagen/chito-
san/HN-300 films was used to examine the CV of our
samples. Figure 7 was the CV of films with 0–10 wt %
HN-300 on the 1st, 3rd, and 5th day. On the 1st day,
all samples had no obvious negative effect on cells,
when compared with films without HN-300. It indi-
cated that the extraction of films with 0–10 wt % HN-
300 did not affect the adhesion of cells. The extraction
Figure 7 The effect of the concentration of HN-300 on the
cell viability of collagen–chitosan films, determined by the
MTT assay. Values are mean (n ¼ 5).
Figure 8 The SEM images of L929 growing on 0%, 5%, 10% HN-300-containing collagen–chitosan films after culture for 4
days.
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of films with 0–2.5 wt % HN-300 accelerated the
growth of cells during the experiment. On the 3rd and
5th day, the extraction of films with 5 wt % HN-300
did not affect cell growth, while the extraction of films
containing 7.5–10% HN-300 would inhibit cell growth
in a certain degree (Fig. 7). HN-300 particle alone was
cytotoxic even when its weight was equal to 0.5 wt %
of collagen–chitosan films. The CV of HN-300 solution
on the 1st, 3rd, and 5th day was 79.6%, 55.6%, 39.2%,
respectively. It indicated that cytotoxicity of HN-300
could be reduced by slowly releasing it from colla-
gen–chitosan film. Collagen/chitosan/HN-300 films
just acted as sustained release system. HN-300 would
improve the antimicrobial function of collagen–chito-
san films, and the films could reduce the cytotoxicity
of HN-300.
Cell compatibility assay
After L929 fibroblasts were cultured for 4 days on the
collagen/chitosan/HN-300 films, SEM was used to
observe the cells on the films as shown in Figure 8.
The fibroblasts grew well on the films containing 0,
2.5, 5, and 7.5 wt % HN-300, but no cell growth was
observed on the films containing 10 wt % HN-300.
From Figure 8, it also could be observed that most of
the cells were polygon or spindle-shaped. They had
plenty of microvilli and pseudopods around them, by
which they contacted with each other and coupled
tightly on the films. This phenomenon indicated that
cells grew well. At the same time, the contact inhibi-
tion also could be observed in the place with a mass of
cells. The inhibition led these cells to form spherical
shape. No cell was found on the films with 10 wt %
HN-300. The SEM results showed that the weight per-
cent of HN-300 in the antimicrobial films should be
less than 10%, to ensure its preferable biocompatibility.
Mechanical property
The mechanical properties of collagen/chitosan/HN-
300 films were shown in Figure 9. The fracture stresses
of all samples were larger than 20 MPa. It was also
revealed from Figure 9 that the fracture stress of the
wound dressing increased from 28.5 MPa to 35.8 MPa
as the concentration of HN-300 was less than 7.5%,
whereas it decreased to 25.7 MPa as the concentration
of HN-300 was 10%. Thus, HN-300 might act as re-
inforcing agent in the wound dressing to enhance the
fracture stress.
CONCLUSIONS
Inorganic antimicrobial particles HN-300 were incor-
porated into the collagen–chitosan wound dressing.
Comparing with AgNO3, HN-300 could protect silver
from oxidation and inactivation, effectively, in the
process of preparing antimicrobial films. The antimi-
crobial property was enhanced with the increase in
the concentration of HN-300. When the concentration
of HN-300 was more than 5%, the films showed sus-
tained and stable antimicrobial property within 144 h.
When the concentration of HN-300 was less than
7.5%, the wound dressings were noncytotoxic and
compatible for L929 fibroblasts. So 5% HN-300 in anti-
microbial films was suitable, and the concentration
also could improve the mechanical properties of the
collagen–chitosan wound dressings. The collagen/
chitosan/HN-300 films could sustain the release of sil-
ver ions, and the cytotoxicity test indicated that the
sustained release reduced the cytotoxicity of HN-300.
Thus, HN-300 improved the antimicrobial function of
collagen–chitosan films, and the films reduced its cy-
totoxicity. After treatment with 5% glycerol, the film’s
stability was enhanced, and silver ions were protected
at the same time. Hence, collagen/chitosan/HN-300
films were of great potential in application as a antimi-
crobial wound dressing.
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